Gameto Secures $44 Million for Phase 3 Stem Cell IVF Study
Gameto, an innovative fertility startup, has successfully raised $44 million to advance its Phase 3 clinical trial of a groundbreaking in vitro fertilization (IVF) therapy utilizing stem cell technology. The…